Paul E. Freiman - Net Worth and Insider Trading
Paul E. Freiman Net Worth
The estimated net worth of Paul E. Freiman is at least $1 dollars as of 2024-04-19. Paul E. Freiman is the Director of NovaBay Pharmaceuticals Inc and owns about 17 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $1. Details can be seen in Paul E. Freiman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul E. Freiman has not made any transactions after 2011-09-12 and currently still holds the listed stock(s).
Transaction Summary of Paul E. Freiman
Paul E. Freiman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul E. Freiman owns 2 companies in total, including NovaBay Pharmaceuticals Inc () , and Neurotrope Inc () .
Click here to see the complete history of Paul E. Freiman’s form 4 insider trades.
Insider Ownership Summary of Paul E. Freiman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc | 2011-09-12 | director | |
| Neurotrope Inc | 2015-11-19 | director & See Remarks |
Paul E. Freiman Latest Holdings Summary
Paul E. Freiman currently owns a total of 1 stock. Paul E. Freiman owns 17 shares of NovaBay Pharmaceuticals Inc (NBY) as of September 12, 2011, with a value of $1.
Latest Holdings of Paul E. Freiman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2011-09-12 | 17 | 0.08 | 1 |
Holding Weightings of Paul E. Freiman
Paul E. Freiman Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul E. Freiman has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 3 shares on September 12, 2011, which cost Paul E. Freiman around $2,520.
Insider Trading History of Paul E. Freiman
- 1
Paul E. Freiman Trading Performance
GuruFocus tracks the stock performance after each of Paul E. Freiman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul E. Freiman is 26.88%. GuruFocus also compares Paul E. Freiman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul E. Freiman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul E. Freiman's insider trading performs compared to the benchmark.
Performance of Paul E. Freiman
Average Return
58.94%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.22 | 26.88 | 32.26 | 58.94 | 22.7 | -3.72 |
| Relative Return to S&P 500(%) | 0.35 | 20.5 | 14.29 | 35.41 | 2.38 | -23.24 |
Paul E. Freiman Ownership Network
Ownership Network List of Paul E. Freiman
Ownership Network Relation of Paul E. Freiman
Paul E. Freiman Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
Paul E. Freiman is the director of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Paul E. Freiman made no insider transaction in NovaBay Pharmaceuticals Inc (). Other recent insider transactions involving NovaBay Pharmaceuticals Inc () include a net sale of 11,921 shares made by Audrey Kunin , and a net sale of 11,921 shares made by Jeffrey Kunin .
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,842 shares of NovaBay Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,842 shares.
NovaBay Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
Paul E. Freiman Mailing Address
Above is the net worth, insider trading, and ownership report for Paul E. Freiman. You might contact Paul E. Freiman via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
